|
Working Group on the Intersection of HIV/AIDS, Violence Against Women and Gender-related Health Disparities
|
Committee, Work group, Advisory group, or Task Force
|
ACF, AHRQ, CDC, HRSA, IHS, SAMHSA
|
NIDA, NIAAA, NICHD, NIMH, OD/DPCPSI/OAR, OD/DPCPSI/ORWH
|
Led by the Office of National AIDS Policy and the US Office of the Vice President, this working group meets once a month via conference calls or in person, as scheduled in advance. This working group was established to respond to one of President’s Obama’s early priorities addressing the domestic HIV/AIDS epidemic. In keeping with the Administration’s commitment to addressing HIV/AIDS, on March 30, 2012, President Obama issued a Presidential Memorandum committing the Administration “to improving efforts to understand and address the intersection of HIV/AIDS, violence against women and girls, and gender-related health disparities.” The memorandum also established an Interagency Federal Working Group and directed Federal agencies to invest resources, focus and coordinate efforts, and share best practices. The working group published a report in September 2013 and since then updated it in October 2014. These reports provide overviews of the efforts to implement the Working Group’s recommendations, Federal activities and community strategies that address the recommendations and next steps needed to further this initiative.
|
|
Working Groups to Develop Federal HIV/AIDS Prevention and Treatment Guidelines
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, HRSA
|
OD/DPCPSI/OAR, NICHD, NIMH
|
Working Groups of HIV experts from across the country, including physicians, pharmacists, researchers, and HIV treatment advocates responsible for writing, reviewing, and updating HIV/AIDS prevention and treatment guidelines.
|
|
Workshop on Research Directions in Genetically-Mediated Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis
|
Meeting/ Workshop
|
FDA
|
NHGRI, CC, NEI, NIAID, NIDDK, NIGMS, NIMH, NINDS
|
Workshop to identify future research directions in Stevens Johnson Syndrome/Toxic Epidermal Necrolysis (SJS/TEN), jointly across multiple NIH ICs and FDA''s pharmacosurveillance group. Goals are to review current state of knowledge of surveillance, pathogenesis, and treatment of SJS/TEN; examine role of genomics and pharmacogenomics in etiology, treatment, and eradication of preventable causes of SJS/TEN; and identify gaps, unmet needs, and priorities for future research to eliminate genetically mediated SJS/TEN globally.
|
|
Yale Specialized Center of Research (SCOR) on Gender-Sensitive Treatment for Tobacco Dependence
|
Research Initiative
|
FDA
|
NIDA
|
The Yale-Specialized Center of Resarch (SCOR) is bringing together leading basic and clinical science experts to establish an interdisciplinary, translational, cross-species program of research aimed at identifying novel therapeutics to address the critical health disparity that female smokers face.
|